piroctone olamine has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, Y; Koller, CM; Schmidt-Wolf, IG | 1 |
| Schmeel, FC; Schmeel, LC; Schmidt-Wolf, IG; Von Schulz-Hausmann, SA | 1 |
2 other study(ies) available for piroctone olamine and Kidney Neoplasms
| Article | Year |
|---|---|
Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciclopirox; Drug Combinations; Ethacrynic Acid; Ethanolamines; Humans; Kidney Neoplasms; Oligopeptides; Peptides; Protein Structure, Tertiary; Pyridones; Wnt Proteins | 2013 |
Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Topics: beta Catenin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Ciclopirox; Drug Combinations; Ethacrynic Acid; Ethanolamines; Humans; Kidney Neoplasms; Pyridones; Wnt Signaling Pathway | 2014 |